Insights

Acquisition Momentum Syapse has undergone multiple acquisitions in 2025 and 2026 by N-Power Medicine, signaling a consolidation trend in precision medicine and real-world evidence platforms that could open cross-sell opportunities across a larger healthcare tech portfolio.

Strategic Partnerships Past and ongoing partnerships with oncology-focused organizations and research groups (Amgen collaboration, Genesis Research Group) indicate a strong channel for joint offerings and integrated real-world evidence solutions within cancer care networks.

Real-World Evidence Focus Specialization in transforming real-world evidence into actionable patient insights aligns with the growing demand from health systems and biopharma for evidence-driven precision medicine and outcomes analytics.

Mid-Sized Enterprise With a lean team size (11-50 employees) and substantial funding history, Syapse presents opportunities for scalable, deployable solutions and services that fit mid-market healthcare providers and regional cancer centers.

Technology Stack Fit Utilizing cloud and data science tooling (Azure, SageMaker), container orchestration (Kubernetes), and automation (Terraform, Jenkins) suggests a readiness for integration with enterprise data platforms, EHR/CRM ecosystems, and scalable analytics workloads that can be aligned with prospective clients' IT roadmaps.

Similar companies to Syapse

Syapse Tech Stack

Syapse uses 8 technology products and services including HashiCorp Terraform, Kubernetes, Jenkins, and more. Explore Syapse's tech stack below.

Media & News

Syapse's Email Address Formats

Syapse uses at least 4 email formats:
Syapse Email FormatsExamplePercentage
First.Last@syapse.comJohn.Doe@syapse.com
68%
First@syapse.comJohn@syapse.com
18%
FirstL@syapse.comJohnD@syapse.com
11%
FirstLast@syapse.comJohnDoe@syapse.com
3%

Frequently Asked Questions

What is Syapse's phone number?

Minus sign iconPlus sign icon
You can contact Syapse's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Syapse's official website and social media links?

Minus sign iconPlus sign icon
Syapse's official website is syapse.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Syapse generate?

Minus sign iconPlus sign icon
As of August 2026, Syapse's annual revenue is estimated to be $1M - $10M.

What is Syapse's SIC code and NAICS code?

Minus sign iconPlus sign icon
Syapse's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Syapse have currently?

Minus sign iconPlus sign icon
As of August 2026, Syapse has approximately 27 employees across 3 continents, including North America, Asia and Europe. Key team members include Head Of Talent Acquisition: J. N., Vice President, Customer Success: J. J. and Controller: B. C. Explore Syapse's employee directory with LeadIQ.

What industry does Syapse belong to?

Minus sign iconPlus sign icon
Syapse operates in the Biotechnology Research industry.

What technology does Syapse use?

Minus sign iconPlus sign icon
Syapse's tech stack includes HashiCorp Terraform, Kubernetes, Jenkins, Salesforce, Redis, Amazon SageMaker, Atlassian Jira and Microsoft Azure.

What is Syapse's email format?

Minus sign iconPlus sign icon
Syapse's email format typically follows the pattern of First.Last@syapse.com. Find more Syapse email formats with LeadIQ.

How much funding has Syapse raised to date?

Minus sign iconPlus sign icon
As of August 2026, Syapse has raised $223M in funding. The last funding round occurred on Jul 27, 2022 for $35M.

When was Syapse founded?

Minus sign iconPlus sign icon
Syapse was founded in 2008.
Syapse logo

Syapse

Biotechnology ResearchCalifornia, United States11-50 Employees

Syapse is a San Francisco–based biotechnology research company focused on turning data gathered from real-world clinical practice into insights that can influence patient care. It enables healthcare organizations to collaborate through open, transparent partnerships, delivering comprehensive patient information to address clinically important questions and applying those insights at the point of care, with a focus on cancer patients and beyond. The organization operates with a relatively small team.

Its customers are healthcare organizations and health systems seeking to advance precision medicine by leveraging shared insights to inform treatment decisions. In the broader biotechnology landscape, Syapse positions itself as a real-world care company that connects providers to extract actionable information from routine care. In January 2025, Syapse was acquired by N-Power Medicine, a firm pursuing reinvention of the clinical trial process.

Section iconCompany Overview

Phone number
Website
syapse.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $223M

    Syapse has raised a total of $223M of funding over 9 rounds. Their latest funding round was raised on Jul 27, 2022 in the amount of $35M as a Venture Round.

  • $1M - $10M

    Syapse's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.